IQVIA director granted 214 deferred share units

IQVIA Holdings Inc. director Colleen A. Goggins received a grant of 214 Deferred Shares on May 7, 2026, as part of her director compensation.

Rhea-AI Filing Summary

IQVIA Holdings Inc. director Colleen A. Goggins received a grant of 214 Deferred Shares on May 7, 2026, as part of her director compensation. Each deferred share is linked to one share of common stock and was valued at $178.64 per deferred share for reporting purposes.

After this grant, Goggins directly holds 5,114 Deferred Shares. These awards convert into common stock upon settlement and become settleable when she ceases to be a director, upon a change in control of the company, or upon her death, with no expiry date.

Insider Trade Summary

Grant/Award: 214 shares

Grant/Award 1 txn

Insider GOGGINS COLLEEN A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred Shares	214	$178.64	$38K

Holdings After Transaction: Deferred Shares — 5,114 contracts (Direct)

Footnotes (1)

1. F1. Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Key Figures

Deferred Shares granted: 214 shares Reported value per Deferred Share: $178.64 per share Deferred Shares held after grant: 5,114 shares +1 more

4 metrics

Deferred Shares granted 214 shares Grant to Colleen A. Goggins on May 7, 2026

Reported value per Deferred Share $178.64 per share Valuation for the May 7, 2026 grant

Deferred Shares held after grant 5,114 shares Total Deferred Shares directly held post-transaction

Underlying common stock 214 shares Common stock underlying the new Deferred Shares grant

Key Terms

Deferred Shares, Non-Employee Director Deferral Plan, change in control

3 terms

Deferred Shares financial

"Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc."

Deferred shares are a class of stock whose economic benefits or certain shareholder rights are delayed or paid later than ordinary shares—for example, dividends may be paid only after other shareholders receive theirs, or voting or redemption rights may be postponed. For investors, that timing difference matters because deferred shares typically offer lower near-term income and different risk, affecting expected returns, priority in payouts, and the share’s market value; think of them like a delayed paycheck compared with a regular salary.

Non-Employee Director Deferral Plan financial

"in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director"

change in control financial

"when the reporting person ceases to be a director, upon a change in control of the Company, or upon death"

A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did IQV director Colleen Goggins report on Form 4 for IQV?

Colleen A. Goggins reported receiving a grant of 214 Deferred Shares on May 7, 2026. Each deferred share corresponds to one IQVIA common share upon settlement, reflecting routine non-employee director compensation rather than an open-market stock purchase or sale.

At what value were Colleen Goggins’ IQVIA Deferred Shares reported?

The 214 Deferred Shares granted to Colleen A. Goggins were reported at $178.64 per share. This value is used for disclosure and compensation reporting purposes and is tied to each deferred share’s underlying IQVIA common stock equivalent.

How many IQVIA Deferred Shares does Colleen Goggins hold after this Form 4 transaction?

Following the May 7, 2026 grant, Colleen A. Goggins holds 5,114 Deferred Shares directly. These represent deferred compensation units linked one-for-one to IQVIA common stock, which will convert into shares when settlement conditions under the deferral plan are met.

When do Colleen Goggins’ IQVIA Deferred Shares convert into common stock?

Each Deferred Share converts into one IQVIA common share upon settlement. The shares become settleable when she ceases to be a director, upon a change in control of the company, or upon her death, as outlined in the Non-Employee Director Deferral Plan.

Do Colleen Goggins’ IQVIA Deferred Shares have an expiration date?

The Deferred Shares reported by Colleen A. Goggins have no expiry date. They remain outstanding until settlement, which occurs upon her departure from the board, a change in control of IQVIA, or her death, according to the company’s director deferral plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/11/2026 - 05:07 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GOGGINS COLLEEN A

(Last) (First) (Middle)

C/O IQVIA HOLDINGS INC.

2400 ELLIS ROAD

(Street)

DURHAM NORTH CAROLINA 27703

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
IQVIA HOLDINGS INC. [ IQV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Shares	(1)	05/07/2026		A		214		(1)	(1)	Common Stock	214	$178.64	5,114	D

Explanation of Responses:

1. Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Remarks:

	/s/ Matthew Gilmartin, Attorney-in-Fact for Colleen A. Goggins	05/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)